Skip to main content
European Network of Centres for Pharmacoepidemiology and Pharmacovigilance
News article27 May 2020European Medicines Agency

EMA calls for high-quality observational research in context of COVID-19

The EMA published a press release on 26 May 2020, calling for for high-quality observational research in the context of COVID-19.

The text emphasises that when planning observational studies, researchers should adhere to existing guidelines on the appropriate design and conduct of pharmacoepidemiological studies in order to generate reliable and reproduceable evidence, including the ENCePP Guide on methodological standards in pharmacoepidemiology. EMA also reminds researchers to post all protocols and reports of observational COVID-19 studies in the EU PAS register to ensure transparency and scrutiny of study design and results.

This text refers to the ENCePP COVID-19 Response Group promoting use and dissemination of valid and reliable methodologies appropriate to COVID-19.

25 MAY 2020
2020 Mandate for ENCePP support to COVID-19 activities
(142.44 KB - PDF)



Publication date
27 May 2020
European Medicines Agency